Skip Nav Destination
Issues
1 November 2015
-
Cover Image
Cover Image
About the Cover
In their article in the current issue, Khare and colleagues report that the receptor subunit shared by IL10 and IL22 is a key factor in the development of colorectal cancer. This “satellite image”–like rendition of the colon is based on a panel from their Fig. 4. Read more about the complex interplay between the shared and unique receptor subunits that generate the signals necessary for tumorigenesis in this research article on pages 1227–1235 in this issue of Cancer Immunology Research. Original micrograph from Gregor Paul, artwork by Lewis Long. - PDF Icon PDF LinkTable of Contents
ISSN 2326-6066
EISSN 2326-6074
Journal Archive
Cancer Immunology Research (2013-Present)
(ISSN 2326-6066) Published monthly since 2013.Cancer Immunity (2001-2013; volumes 1-13)
(EISSN 1424-9634) Published periodically from 2001-2013.Table of Contents
Milestones in Cancer Immunology
Cancer Immunology at the Crossroads: Experimental Immunotherapies
Cancer Immunology Miniatures
Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report
Isabella C. Glitza; Cara Haymaker; Chantale Bernatchez; Luis Vence; Michelle Rohlfs; Jessie Richard; Carol Lacey; Rahmatu Mansaray; Orenthial J. Fulbright; Renjith Ramachandran; Christopher Toth; Seth Wardell; Sapna P. Patel; Scott E. Woodman; Wen-Jen Hwu; Laszlo G. Radvanyi; Michael A. Davies; Nicholas E. Papadopoulos; Patrick Hwu
Research Articles
Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
Jai Rautela; Nikola Baschuk; Clare Y. Slaney; Krishnath M. Jayatilleke; Kun Xiao; Bradley N. Bidwell; Erin C. Lucas; Edwin D. Hawkins; Peter Lock; Christina S. Wong; Weisan Chen; Robin L. Anderson; Paul J. Hertzog; Daniel M. Andrews; Andreas Möller; Belinda S. Parker
Author Choice
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
Fokhrul Hossain; Amir A. Al-Khami; Dorota Wyczechowska; Claudia Hernandez; Liqin Zheng; Krzystoff Reiss; Luis Del Valle; Jimena Trillo-Tinoco; Tomasz Maj; Weiping Zou; Paulo C. Rodriguez; Augusto C. Ochoa
Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury
Christopher R. Heery; B. Harpreet Singh; Myrna Rauckhorst; Jennifer L. Marté; Renee N. Donahue; Italia Grenga; Timothy C. Rodell; William Dahut; Philip M. Arlen; Ravi A. Madan; Jeffrey Schlom; James L. Gulley
Author Choice
Extracellular Vesicles Present in Human Ovarian Tumor Microenvironments Induce a Phosphatidylserine-Dependent Arrest in the T-cell Signaling Cascade
Raymond J. Kelleher, Jr; Sathy Balu-Iyer; Jenni Loyall; Anthony J. Sacca; Gautam N. Shenoy; Peng Peng; Vandana Iyer; Anas M. Fathallah; Charles S. Berenson; Paul K. Wallace; Joseph Tario; Kunle Odunsi; Richard B. Bankert
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.